Article
Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.
Respirology (Carlton, Vic.) - 1 Jan 2012
Tseden-Ish Manaljav, Choi Yoo-Duk, Cho Hyun-Ju, Ban Hee-Jung, Oh In-Jae, Kim Kyu-Sik, Song Sang-Yun, Na Kook-Joo, Ahn Sung-Ja, Choi Song, Kim Young-Chul
Abstract excerpt
BACKGROUND AND OBJECTIVE: Expression of excision repair cross-complementation group 1 (ERCC1) is recognized as a favourable prognostic marker in patients who have undergone surgical resection of non-small cell lung cancer (NSCLC). However, in patients treated with adjuvant chemotherapy after surgical resection, ERCC1 correlated with poor prognosis. Class III beta tubulin (TUBB3) is also known to be a predictive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.